Radiosynthesis and biodistribution of a histamine H3 receptor antagonist 4-[3-(4-piperidin-1-yl-but-1-ynyl)-[11C]benzyl]-morpholine: evaluation of a potential PET ligand
✍ Scribed by Anu J. Airaksinen; Jill A. Jablonowski; Margreet van der Mey; Ann J. Barbier; Rob P. Klok; Joost Verbeek; Robert Schuit; Jacobus D.M. Herscheid; Josee E. Leysen; Nicholas I. Carruthers; Adriaan A. Lammertsma; Albert D. Windhorst
- Book ID
- 116799011
- Publisher
- Elsevier Science
- Year
- 2006
- Tongue
- English
- Weight
- 526 KB
- Volume
- 33
- Category
- Article
- ISSN
- 0969-8051
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract In order to perform __in vivo__ imaging of the NR2B NMDA receptor system by positron emission tomography, a NR2B selective NMDA receptor antagonist has been labelled with carbon‐11 (half‐life: 20 min). __N__‐[4‐(4‐fluorobenzyl)piperidin‐1‐yl]‐__N__′‐(2‐oxo‐1,3‐dihydrobenzimidazol‐5‐yl)o
## Abstract Two novel ligands for cerebral cannabinoid receptor (CB1), 1‐(2,4‐dichlorophenyl)‐4‐cyano‐5‐(4‐methoxyphenyl)‐__N__‐(piperidin‐1‐yl)‐1__H__‐pyrazole‐3‐carboxamide (JHU75528) and 1‐(2‐bromophenyl)‐4‐cyano‐5‐(4‐methoxyphenyl)‐__N__‐(piperidin‐1‐yl)‐1__H__‐pyrazole‐3‐carboxamide (JHU75575)